Candel Therapeutics (CADL) Institutional Ownership $8.75 -1.21 (-12.15%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Candel Therapeutics (NASDAQ:CADL)CurrentInstitutional OwnershipPercentage13.93%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$1.89MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$3.13M Get CADL Insider Trade Alerts Want to know when executives and insiders are buying or selling Candel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CADL Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Candel Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC28,688$199K0.0%+327.1%0.088% 11/16/2024 Geode Capital Management LLC448,997$3.11M0.0%+12.8%1.399% 11/15/2024 Barclays PLC28,688$199K0.0%+327.1%0.089% 11/15/2024 MML Investors Services LLC22,313$155K0.0%-69.6%0.070% 11/15/2024 State Street Corp492,005$3.41M0.0%+4.1%1.534% 11/15/2024 Atom Investors LP14,873$103K0.0%N/A0.046% Get the Latest News and Ratings for CADL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024 MetLife Investment Management LLC12,558$87K0.0%N/A0.039% 11/13/2024 FMR LLC6,573$46K0.0%N/A0.020% 9/16/2024 Point72 DIFC Ltd4,927$31K0.0%N/A0.017% 9/16/2024 Cubist Systematic Strategies LLC26,121$162K0.0%N/A0.088% 8/14/2024 Cubist Systematic Strategies LLC26,121$162K0.0%N/A0.088% 8/14/2024 Point72 DIFC Ltd4,927$31K0.0%N/A0.017% 8/13/2024 Sands Capital Ventures LLC405,837$2.52M0.8%-50.0%1.364% 8/9/2024 Renaissance Technologies LLC20,600$128K0.0%-63.8%0.069% 8/1/2024 Rhumbline Advisers22,985$143K0.0%N/A0.077% 7/26/2024 Bank of New York Mellon Corp54,449$338K0.0%N/A0.183% 1/29/2024Baystate Wealth Management LLC76,910$113K0.0%-21.0%0.266% 5/10/2023 Resources Investment Advisors LLC.25,428$34K0.0%N/A0.088% 4/25/2023Baystate Wealth Management LLC105,854$143K0.0%N/A0.366% 11/14/2022 Point72 Asset Management L.P.403,131$1.27M0.0%-45.7%1.395% 5/6/2022 Empirical Asset Management LLC12,000$61K0.1%N/A0.042% 4/26/2022 Kestra Advisory Services LLC12,500$64K0.0%N/A0.044% 2/15/2022 Northpond Ventures LLC1,935,215$15.13M5.3%N/A6.745% 2/15/2022 683 Capital Management LLC40,929$320K0.0%N/A0.143% 11/15/2021 Caas Capital Management LP50,000$542K0.0%N/A0.174% 11/15/2021 Franklin Resources Inc.1,125,000$12.20M0.0%N/A3.921% 11/9/2021BlackRock Inc.22,326$242K0.0%N/A0.078% (Data available from 1/1/2016 forward) CADL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CADL shares? During the previous two years, 15 institutional investors and hedge funds held shares of Candel Therapeutics. The most heavily invested institutionals were State Street Corp ($3.41M), Geode Capital Management LLC ($3.11M), Sands Capital Ventures LLC ($2.52M), Bank of New York Mellon Corp ($338K), Barclays PLC ($199K), Cubist Systematic Strategies LLC ($162K), and MML Investors Services LLC ($155K).Learn more on CADL's institutional investors. What percentage of Candel Therapeutics stock is owned by institutional investors? 13.93% of Candel Therapeutics stock is owned by institutional investors. Learn more on CADL's institutional investor holdings. Which institutional investors have been buying Candel Therapeutics stock? Of the 12 institutional investors that purchased Candel Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baystate Wealth Management LLC ($105.85K), Bank of New York Mellon Corp ($54.45K), Cubist Systematic Strategies LLC ($52.24K), Geode Capital Management LLC ($51.11K), Barclays PLC ($43.94K), Resources Investment Advisors LLC. ($25.43K), and Rhumbline Advisers ($22.99K). How much institutional buying is happening at Candel Therapeutics? Institutional investors have bought a total of 419,076 shares in the last 24 months. This purchase volume represents approximately $2.07M in transactions. Which Candel Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Candel Therapeutics stock in the last 24 months: Sands Capital Ventures LLC ($405.90K), MML Investors Services LLC ($51.06K), Renaissance Technologies LLC ($36.31K), and Baystate Wealth Management LLC ($20.40K). How much institutional selling is happening at Candel Therapeutics? Institutional investors have sold a total of 513,668 shares in the last 24 months. This volume of shares sold represents approximately $3.13M in transactions. Related Companies IMNM Institutional Ownership KURA Institutional Ownership KROS Institutional Ownership TYRA Institutional Ownership CRON Institutional Ownership ERAS Institutional Ownership EOLS Institutional Ownership DNTH Institutional Ownership RAPP Institutional Ownership AUTL Institutional Ownership This page (NASDAQ:CADL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Candel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Candel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CADL Stock Alerts